At a glance
ClinicalIndex Comparison RecordN/ACompleted· 380 enrolled
Drug / intervention
Quality-of-Life Assessment +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
In Brief
An observational study evaluating Quality-of-Life Assessment and Questionnaire Administration for Stage IVA Colon Cancer and 3 related conditions. Completed, enrolled 380 participants across 537 sites.
Detailed Summary
This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartJun 2016
Primary CompletionApr 2020
Study CompletionNov 2020
TodayJul 2026
First PostedApr 5, 2016
Enrollment StartJun 22, 2016
Primary CompletionApr 15, 2020
Study CompletionNov 13, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.2 years ago
Interventions
Quality-of-Life Assessmentother
Complete questionnaire
Questionnaire Administrationother
Complete questionnaires